We aim to discuss the potential causes of ECS, evaluate the effectiveness of tumor debulking, steroidogenesis inhibitors, tyrosine kinase inhibitors (TKIs), bilateral adrenalectomy (BLA), and a new selective RET inhibitor in treating MEN 2-related MTC and ECS. This evidence concerns the gene RET and neoplasm.